Impact of short course hormonal therapy on overall and cancer specific survival after permanent prostate brachytherapy

This publication has 24 references indexed in Scilit:

• The Changing Face of Low-Risk Prostate Cancer: Trends in Clinical Presentation and Primary Management
  Journal of Clinical Oncology, 2004
• Relative influence of Gleason score and pretreatment PSA in predicting survival following brachytherapy for prostate cancer
  Brachytherapy, 2003
• Updated results of the phase III Radiation Therapy Oncology Group (RTOG) trial 85-31 evaluating the potential benefit of androgen suppression following standard radiation therapy for unfavorable prognosis carcinoma of the prostate
  International Journal of Radiation Oncology*Biology*Physics, 2001
• The Evolving Role of Prostate Brachytherapy
  Cancer Control, 2001
• Real-time optimized intraoperative dosimetry for prostate brachytherapy: A pilot study
  International Journal of Radiation Oncology*Biology*Physics, 2000
• Biochemical Outcome Following External Beam Radiation Therapy With or Without Androgen Suppression Therapy for Clinically Localized Prostate Cancer
  JAMA, 2000
• Prostate cancer patient subsets showing improved bNED control with adjuvant androgen deprivation
  International Journal of Radiation Oncology*Biology*Physics, 1997
• Improved Survival in Patients with Locally Advanced Prostate Cancer Treated with Radiotherapy and Goserelin
  New England Journal of Medicine, 1997
• Radiotherapy and androgen ablation for clinically localized high-risk prostate cancer
  International Journal of Radiation Oncology*Biology*Physics, 1995
• Improved control of bulky prostate carcinoma with sequential estrogen and radiation therapy
  International Journal of Radiation Oncology*Biology*Physics, 1984